Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Delayed Quote USD

Citius Oncology, Inc. (CTOR)

Compare
0.8600
-0.0700
(-7.53%)
At close: April 1 at 4:00:01 PM EDT
0.8350
-0.03
(-2.91%)
Pre-Market: 4:55:43 AM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue --
Earnings -6.66M

Q3'24

Q4'24

-6M
-4M
-2M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

3.00
3.00 Average
0.8600 Current
3.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1111
Avg. Estimate 5.74M8.6M28.68M72.88M
Low Estimate 5.74M8.6M28.68M72.88M
High Estimate 5.74M8.6M28.68M72.88M
Year Ago Sales ------28.68M
Sales Growth (year/est) ----0.00%154.12%

Earnings History

Currency in USD 9/30/2024 12/31/2024
EPS Est. -0.08-0.06
EPS Actual -0.1-0.09
Difference -0.02-0.03
Surprise % -25.00%-50.00%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
CTOR --------
S&P 500 6.69%6.80%9.98%14.34%

Upgrades & Downgrades

Initiated Maxim Group: Buy 11/27/2024
Maintains EF Hutton: Buy to Buy 8/13/2024

Related Tickers